CEO's large proposed sale (~$33.6M) signals potential insider distribution; monitor for actual Form 4 filings to confirm execution. The sale is concurrent with option exercise, suggesting a planned liquidity event rather than a distress signal, but the magnitude relative to market cap is notable. Watch for any subsequent insider selling patterns or changes in guidance.
Price Chart
Executive Summary
CEO Dinesh Patel filed a Form 144 notice of intent to sell 225,000 shares of Protagonist Therapeutics (PTGX) through J.P. Morgan Securities, with an estimated aggregate market value of approximately $33.6 million based on the filing date. This represents a large proposed sale relative to Patel's remaining holdings of ~64.7 million shares, but the CEO's intent to sell a meaningful stake signals potential insider distribution at a $9.4B market cap company.
Key Facts
- CEO Dinesh Patel filed Form 144 to sell 225,000 shares of PTGX common stock.
- Estimated aggregate market value of the proposed sale is $33,583,500.
- Patel holds approximately 64,708,285 shares after the proposed sale (post-sale holdings).
- The shares to be sold were acquired via option exercise on August 10, 2026.
- The sale is planned through J.P. Morgan Securities LLC as agent.
- The filing date is August 10, 2026; the proposed sale date is also August 10, 2026.
Financial Impact
CEO proposes to sell ~$33.6M worth of stock, representing ~0.35% of market cap and ~0.35% of his post-sale holdings.
Risk Factors
- CEO selling a large dollar amount could signal lack of confidence or need for liquidity.
- The sale may be executed quickly (same-day filing and proposed sale date), increasing near-term selling pressure.
- If the sale is completed, it could weigh on sentiment given the $9.4B market cap and 90% analyst bullishness.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001968582-26-000805 |
| Document: 0001968582-26-000805-index.html | 0001968582-26-000805 |
| Document: 0001968582-26-000805.txt | 0001968582-26-000805 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 10, 2026 7w ago | 144 | $148.29 $145.09 | ▲ +2.16% | ▲ +1.10% | $140.06 (+5.55%) |
Jun 18, 2026 15w ago | 8-K | $115.03 $140.91 | ▲ +22.50% | ▲ +22.65% | $140.06 (+21.76%) |
Jun 12, 2026 16w ago | Institutional Cluster | $109.78 $131.42 | ▲ +19.71% | ▲ +17.93% | $140.06 (+27.58%) |
May 12, 2026 20w ago | 144 | $103.88 $109.79 | ▼ −5.69% | ▼ −6.30% | $140.06 (−34.83%) |
May 8, 2026 21w ago | Insider Cluster | $99.36 $97.38 | ▼ −1.99% | ▼ −2.02% | $140.06 (+40.96%) |
May 8, 2026 21w ago | Insider Cluster | $99.36 $97.38 | ▼ −1.99% | ▼ −2.02% | $140.06 (+40.96%) |
May 5, 2026 21w ago | 8-K | $103.97 $95.41 | ▼ −8.23% | ▼ −11.01% | $140.06 (+34.71%) |
Feb 25, 2026 31w ago | 8-K | $87.10 $104.31 | ▲ +19.76% | ▲ +25.00% | $140.06 (+60.80%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access